Related Experiment Videos
Nosocomial pneumonia
1Department of Internal Medicine, University of Texas Health Science Center, Dallas.
Abstract:
Nosocomial pneumonias are a particularly problematic group of infections. The pathogenesis of these pneumonias, including mechanisms of colonization and pulmonary defense mechanisms, is discussed. An approach to the hospitalized patient with fever and infiltrates, based on the clinical setting, the nature of the host defense defect, the radiographic findings, and the results of invasive diagnostic procedures, is presented. Antimicrobial agents available to treat patients with nosocomial pneumonia are reviewed.
Insights
Nosocomial pneumonias, hospital-acquired infections, are challenging. This review discusses their causes, host defenses, and diagnostic approaches for hospitalized patients with fever and infiltrates.
Area of Science:
- Infectious Diseases
- Pulmonology
- Critical Care Medicine
Background:
- Nosocomial pneumonias represent a significant challenge in healthcare settings.
- Understanding the pathogenesis, including colonization and host defense, is crucial.
Purpose of the Study:
- To discuss the pathogenesis of nosocomial pneumonias.
- To present a diagnostic approach for hospitalized patients with fever and infiltrates.
- To review available antimicrobial agents for treatment.
Main Methods:
- Literature review on the pathogenesis of nosocomial pneumonias.
- Clinical approach based on patient setting, host defenses, and radiographic findings.
- Review of diagnostic procedures and antimicrobial therapies.
Main Results:
- Discussion of colonization and pulmonary defense mechanisms in pneumonia.
- A structured approach to diagnosing pneumonia in hospitalized patients is outlined.
- Overview of current antimicrobial agents for treating nosocomial pneumonia.
Conclusions:
- Effective management requires understanding pathogenesis and employing a systematic diagnostic strategy.
- Appropriate antimicrobial selection is vital for successful treatment outcomes.
- Further research into host defense and novel therapies is warranted.